$SDGR
Schrodinger, Inc. Stock $sdgr

$sdgr Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000156459021010727 Filed on March 04, 2021

Income Statement

Concept	2020 Q4	2020	2019 Q4
Revenue	$33.03M	$108.1M	$25.83M
YoY Change	27.87%	26.36%	47.77%
Cost Of Revenue	$14.04M	$44.62M	$10.31M
YoY Change	36.18%	22.42%	43.79%
Gross Profit	$18.99M	$63.47M	$15.53M
YoY Change	22.28%	29.29%	50.63%
Gross Profit Margin	57.49%	58.72%	60.12%
Selling, General & Admin	$18.26M	$59.69M	$11.77M
YoY Change	55.14%	23.32%	22.6%
% of Gross Profit	96.16%	94.05%	75.79%
Research & Development	$17.32M	$64.70M	$10.93M
YoY Change	58.46%	64.18%	25.2%
% of Gross Profit	91.21%	101.93%	70.38%
Depreciation & Amortization	$1.010M	$3.658M	$910.0K
YoY Change	10.99%	0.49%	4.6%
% of Gross Profit	5.32%	5.76%	5.86%
Operating Expenses	$35.58M	$124.4M	$23.37M
YoY Change	52.25%	41.66%	23.13%
Operating Profit	-$16.59M	-$60.92M	-$7.840M
YoY Change	111.61%	57.34%	-9.57%
Interest Expense	$5.220M	$34.60M	$670.0K
YoY Change	679.1%	172.44%	-67.79%
% of Operating Profit
Other Income/Expense, Net		$34.62M
YoY Change		171.71%
Pretax Income	-$11.36M	-$26.29M	-$7.170M
YoY Change	58.44%	1.23%	8.8%
Income Tax	$230.0K	$345.0K	-$30.00K
% Of Pretax Income
Net Earnings	-$11.14M	-$24.46M	-$6.770M
YoY Change	64.55%	-0.44%	6.28%
Net Earnings / Revenue	-33.73%	-22.63%	-26.21%
Basic Earnings Per Share		-$0.41
Diluted Earnings Per Share	-$159.9K	-$408.3K	-$110.2K
COMMON SHARES
Basic Shares Outstanding		60.02M shares
Diluted Shares Outstanding		60.02M shares

Balance Sheet

Concept	2020 Q4	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$642.7M	$642.7M	$85.80M
YoY Change	649.07%	649.07%
Cash & Equivalents	$202.3M	$202.3M	$25.99M
Short-Term Investments	$440.4M	$440.4M	$59.80M
Other Short-Term Assets	$4.900M	$4.900M	$7.000M
YoY Change	-30.0%	-30.0%
Inventory
Prepaid Expenses	$4.409M		$6.468M
Receivables	$31.42M	$35.00M	$18.68M
Other Receivables	$4.000M	$400.0K	$7.000M
Total Short-Term Assets	$683.0M	$683.0M	$118.5M
YoY Change	476.18%	476.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.140M	$15.30M	$6.268M
YoY Change	-18.0%	-19.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$45.66M	$45.70M	$15.37M
YoY Change	197.18%	196.75%
Other Assets	$2.352M	$2.400M	$2.338M
YoY Change	0.6%	4.35%
Total Long-Term Assets	$63.29M	$63.30M	$36.73M
YoY Change	72.28%	72.01%
TOTAL ASSETS
Total Short-Term Assets	$683.0M	$683.0M	$118.5M
Total Long-Term Assets	$63.29M	$63.30M	$36.73M
Total Assets	$746.3M	$746.3M	$155.3M
YoY Change	380.62%	380.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.398M	$8.400M	$3.524M
YoY Change	138.31%	140.0%
Accrued Expenses	$19.40M	$19.40M	$16.40M
YoY Change	18.29%	18.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$73.21M	$73.20M	$45.02M
YoY Change	62.61%	62.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$654.0K	$49.00M	$900.0K
YoY Change	-27.33%	308.33%
Total Long-Term Liabilities	$654.0K	$49.00M	$900.0K
YoY Change	-27.33%	308.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.21M	$73.20M	$45.02M
Total Long-Term Liabilities	$654.0K	$49.00M	$900.0K
Total Liabilities	$122.2M	$122.2M	$57.01M
YoY Change	114.41%	114.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$129.6M		-$105.1M
YoY Change	23.28%
Common Stock	$753.2M		$11.72M
YoY Change	6328.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$624.0M	$624.0M	-$93.36M
YoY Change
Total Liabilities & Shareholders Equity	$746.3M	$746.3M	$155.3M
YoY Change	380.62%	380.55%

Cashflow Statement

Concept	2020 Q4	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	-$11.14M	-$24.46M	-$6.770M
YoY Change	64.55%	-0.44%	6.28%
Depreciation, Depletion And Amortization	$1.010M	$3.658M	$910.0K
YoY Change	10.99%	0.49%	4.6%
Cash From Operating Activities	$43.62M	$16.76M	-$11.27M
YoY Change	-487.05%	-164.3%	19.77%
INVESTING ACTIVITIES
Capital Expenditures	-$890.0K	$2.538M	-$160.0K
YoY Change	456.25%	38.24%	-50.0%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$52.35M	-$379.2M	$6.530M
YoY Change	-901.68%	628.91%	625.56%
Cash From Investing Activities	-$53.24M	-$381.7M	$6.370M
YoY Change	-935.79%	608.79%	998.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.420M	541.3M	-1.720M
YoY Change	-182.56%	1787.02%	-102.17%
NET CHANGE
Cash From Operating Activities	43.62M	16.76M	-11.27M
Cash From Investing Activities	-53.24M	-381.7M	6.370M
Cash From Financing Activities	1.420M	541.3M	-1.720M
Net Change In Cash	-8.200M	176.3M	-6.620M
YoY Change	23.87%	-444.15%	-109.38%
FREE CASH FLOW
Cash From Operating Activities	$43.62M	$16.76M	-$11.27M
Capital Expenditures	-$890.0K	$2.538M	-$160.0K
Free Cash Flow	$44.51M	$14.22M	-$11.11M
YoY Change	-500.63%	-150.97%	22.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 West 45th Street
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	17th Floor
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10036
CY2020	dei	City Area Code CityAreaCode	212
CY2020	dei	Local Phone Number LocalPhoneNumber	295-5800
CY2020	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	60000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-129559000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	317000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	624015000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	624019000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	4000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	746263000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-24463000
CY2020	dei	Trading Symbol TradingSymbol	SDGR
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	2187273894
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	202296000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25986000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	440395000
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	59844000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31423000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18676000
CY2020Q4	sdgr	Unbilled And Other Receivables Current UnbilledAndOtherReceivablesCurrent	3955000
CY2019Q4	sdgr	Unbilled And Other Receivables Current UnbilledAndOtherReceivablesCurrent	7062000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4409000
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6468000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	682978000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	118536000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5140000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6268000
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	45664000
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	15366000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10129000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12762000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2352000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2338000
CY2020Q4	us-gaap	Assets Assets	746263000
CY2019Q4	us-gaap	Assets Assets	155270000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8398000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3524000
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	12000000
CY2019Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	7034000
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	45403000
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25054000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4543000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5584000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2861000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3824000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73205000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45020000
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	41164000
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2205000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7221000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8888000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	654000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	900000
CY2020Q4	us-gaap	Liabilities Liabilities	122244000
CY2019Q4	us-gaap	Liabilities Liabilities	57013000
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	191580000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	607000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	61000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	752558000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11655000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-105096000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-93364000
CY2019Q4	us-gaap	Minority Interest MinorityInterest	41000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-93323000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155270000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	425000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60713534
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6121821
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60713534
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6121821
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	44623000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	36450000
CY2020	us-gaap	Gross Profit GrossProfit	63472000
CY2019	us-gaap	Gross Profit GrossProfit	49093000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64695000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39404000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17795000
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21364000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41898000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27040000
CY2020	us-gaap	Operating Expenses OperatingExpenses	124388000
CY2019	us-gaap	Operating Expenses OperatingExpenses	87808000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-60916000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-38715000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4108000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	943000
CY2020	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	28263000
CY2019	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	9922000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	2253000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	1878000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34624000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12743000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26292000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25972000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-291000
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.09
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60024658
CY2019	sdgr	Investment Accretion Noncash Expense InvestmentAccretionNoncashExpense	506000
CY2019	sdgr	Increase Decrease In Unbilled And Other Receivables IncreaseDecreaseInUnbilledAndOtherReceivables	1556000
CY2019	sdgr	Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets	-4177000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-410000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6004500
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	301000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	25000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24162000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24546000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-71560000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	549000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2193000
CY2019	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1151000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4183000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10545000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	149824000
CY2020	sdgr	Exchange Of Convertible Preferred Stock Into Limited Common Stock Value ExchangeOfConvertiblePreferredStockIntoLimitedCommonStockValue	41756000
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2137000
CY2020	sdgr	Noncash Revenue From Equity Investments NoncashRevenueFromEquityInvestments	397000
CY2019	sdgr	Noncash Revenue From Equity Investments NoncashRevenueFromEquityInvestments	186000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3658000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3640000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10545000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	2193000
CY2020	sdgr	Research And Development Noncash Expense ResearchAndDevelopmentNoncashExpense	2137000
CY2019	sdgr	Research And Development Noncash Expense ResearchAndDevelopmentNoncashExpense	1051000
CY2020	sdgr	Investment Accretion Noncash Expense InvestmentAccretionNoncashExpense	-646000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12747000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5038000
CY2020	sdgr	Increase Decrease In Unbilled And Other Receivables IncreaseDecreaseInUnbilledAndOtherReceivables	-3468000
CY2020	sdgr	Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssets	-5342000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-187000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4882000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4966000
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	59705000
CY2020	sdgr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-5417000
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1210000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16757000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2538000
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2869000
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	4582000
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	943000
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	110187000
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	57225000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53855000
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	211491000
CY2020	sdgr	Proceeds From Issuance Upon Follow On Public Offering Net ProceedsFromIssuanceUponFollowOnPublicOfferingNet	325600000
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	29893000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4183000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	549000
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	100000
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1858000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	541274000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28684000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	176310000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-51230000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77716000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	202796000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	381000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	139000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	138772000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-381721000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-294000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2948000
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6715000
CY2019	sdgr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-4025000
CY2019	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	958000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26059000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1836000
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	519668000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26486000
CY2019	sdgr	Accrued Deferred Offering Costs AccruedDeferredOfferingCosts	2142000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	8000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	90000
CY2020	sdgr	Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations	2709000
CY2019	sdgr	Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations	464000
CY2019	sdgr	Noncash Or Part Noncash Right Of Use Assets Recognized On Adoption NoncashOrPartNoncashRightOfUseAssetsRecognizedOnAdoption	16475000
CY2020	sdgr	Noncash Or Part Noncash Reclassification Of Deferred Financing Costs To Additional Paid In Capital NoncashOrPartNoncashReclassificationOfDeferredFinancingCostsToAdditionalPaidInCapital	1858000
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</font><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">k</font><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</font></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;font-style:normal;"></font>Concentrations</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade receivables.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not require customers to provide collateral to support accounts receivable. If deemed necessary, credit reviews of significant new customers may be performed prior to extending credit. The determination of a customer’s ability to pay requires judgment, and failure to collect from a customer can adversely affect revenue, cash, and net income. The Company maintains an allowance for doubtful accounts.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, two customers accounted for 17% and 14% of total accounts receivable, respectively. As of December 31, 2019, one customer accounted for 10% of total accounts receivable. For the year ended December 31, 2020, no customer accounted for more than 10% of total revenues. For the year ended December 31, 2019, one customer accounted for 12% of total revenues.</p>
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	185614000
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	20208000
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2020	us-gaap	Royalty Expense RoyaltyExpense	7663000
CY2019	us-gaap	Royalty Expense RoyaltyExpense	7352000
CY2020	sdgr	Commission Expense CommissionExpense	1362000
CY2019	sdgr	Commission Expense CommissionExpense	754000
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	3589000
CY2019Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	6904000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24921000
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	17720000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.52
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	29147000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18942000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11764000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	583000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	178000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-95000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	167000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16830000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13802000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10562000
CY2020	us-gaap	Depreciation Depreciation	3658000
CY2019	us-gaap	Depreciation Depreciation	3625000
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	485965000
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	74280000
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4288000
CY2019	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-4180000
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	108000
CY2020	sdgr	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Cash Contributions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetCashContributions	2869000
CY2020	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-2977000
CY2020Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2019Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2020Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2019Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2020	sdgr	Operating Lease Expiration Year OperatingLeaseExpirationYear	2029
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0501
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2020	sdgr	Increase In Operating Lease Right Of Use Asset IncreaseInOperatingLeaseRightOfUseAsset	2709000
CY2020	sdgr	Increase In Operating Lease Liabilities IncreaseInOperatingLeaseLiabilities	2709000
CY2020	us-gaap	Lease Cost LeaseCost	0
CY2020	sdgr	Number Of New Operating Leases NumberOfNewOperatingLeases	2
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	5895000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	5181000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	6050000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	5108000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4622000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1892000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1760000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1777000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1328000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	962000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12341000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	577000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-779000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	345000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-291000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-24567000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-25385000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	449000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	523000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-24118000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-24862000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.142
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042
CY2019	sdgr	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	-0.023
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.062
CY2020	sdgr	Effective Income Tax Rate Reconciliation Section162 Limitation EffectiveIncomeTaxRateReconciliationSection162Limitation	-0.128
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.685
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.002
CY2020	sdgr	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	-0.013
CY2019	sdgr	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	0.032
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.005
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.950
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.313
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.052
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.006
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	10477000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	7097000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	8752000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	7468000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.016
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.014
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.009
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	22904000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	51498000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26119000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	70727000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40684000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58155000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35251000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12572000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5433000
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	10185000
CY2019Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1984000
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	889000
CY2019Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	441000
CY2020Q4	sdgr	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	1498000
CY2019Q4	sdgr	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	3008000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	206311000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	126729000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	902000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	781000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	25000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	24000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	16000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	12000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	135000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	109000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1046000
CY2020	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	As of December 31, 2020, statutes of limitations were open for all of the Company’s federal and state tax returns filed after the year ended December 31, 2015 and 2014, respectively. Net operating loss and credit carryforwards for all years are subject to examination and adjustments for the three years following the year in which the carryforwards are utilized. The Company is not currently undergoing any federal or state income tax examinations.
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1398177
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	214845
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.60
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.57
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y5M26D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y18D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0146
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0233
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10545000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2193000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4943778
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3912383
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	129315
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	71209
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7257460
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1978647
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.57
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	19.49
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.99
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	12.20
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.98
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.14
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.57
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y21D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M8D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	486572000
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	149604000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.55
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.93
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	87946000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	546000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3153000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1734000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7257460
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47540446
CY2020Q4	sdgr	Non Marketable Equity Securities NonMarketableEquitySecurities	94000
CY2019Q4	sdgr	Non Marketable Equity Securities NonMarketableEquitySecurities	930000
CY2020	us-gaap	Description Of Defined Contribution Pension And Other Postretirement Plans DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans	401(k) employee savings plan to its U.S.based employees
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1.00
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.040
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1748000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1492000
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2

Files In Submission

Name	View Source	Status
0001564590-21-010727-index-headers.html	Edgar Link	pending
0001564590-21-010727-index.html	Edgar Link	pending
0001564590-21-010727.txt	Edgar Link	pending
0001564590-21-010727-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gf04o5n3tvxk000001.jpg	Edgar Link	pending
gv2w1w032imk000001.jpg	Edgar Link	pending
gv2w1w032imk000002.jpg	Edgar Link	pending
gv2w1w032imk000003.jpg	Edgar Link	pending
gv2w1w032imk000004.jpg	Edgar Link	pending
gv2w1w032imk000005.jpg	Edgar Link	pending
gv2w1w032imk000006.jpg	Edgar Link	pending
gv2w1w032imk000007.jpg	Edgar Link	pending
gv2w1w032imk000008.jpg	Edgar Link	pending
gv2w1w032imk000009.jpg	Edgar Link	pending
gv2w1w032imk000010.jpg	Edgar Link	pending
gv2w1w032imk000011.jpg	Edgar Link	pending
gv2w1w032imk000012.jpg	Edgar Link	pending
gv2w1w032imk000013.jpg	Edgar Link	pending
gv2w1w032imk000014.jpg	Edgar Link	pending
gv2w1w032imk000015.jpg	Edgar Link	pending
gv2w1w032imk000016.jpg	Edgar Link	pending
gv2w1w032imk000017.jpg	Edgar Link	pending
gv2w1w032imk000018.jpg	Edgar Link	pending
gv2w1w032imk000019.jpg	Edgar Link	pending
gv2w1w032imk000020.jpg	Edgar Link	pending
gv2w1w032imk000021.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sdgr-10k_20201231.htm	Edgar Link	pending
sdgr-20201231.xml	Edgar Link	completed
sdgr-20201231.xsd	Edgar Link	pending
sdgr-20201231_cal.xml	Edgar Link	unprocessable
sdgr-20201231_def.xml	Edgar Link	unprocessable
sdgr-20201231_lab.xml	Edgar Link	unprocessable
sdgr-20201231_pre.xml	Edgar Link	unprocessable
sdgr-ex1037_103.htm	Edgar Link	pending
sdgr-ex1038_367.htm	Edgar Link	pending
sdgr-ex1039_368.htm	Edgar Link	pending
sdgr-ex1040_365.htm	Edgar Link	pending
sdgr-ex1041_366.htm	Edgar Link	pending
sdgr-ex107_364.htm	Edgar Link	pending
sdgr-ex231_12.htm	Edgar Link	pending
sdgr-ex311_10.htm	Edgar Link	pending
sdgr-ex312_11.htm	Edgar Link	pending
sdgr-ex321_8.htm	Edgar Link	pending
sdgr-ex322_9.htm	Edgar Link	pending
sdgr-ex43_186.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SDGR
Schrodinger, Inc. Stock $sdgr

2020 Q4 Form 10-K Financial Statement

#000156459021010727 Filed on March 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SDGR Schrodinger, Inc. Stock $sdgr

2020 Q4 Form 10-K Financial Statement

#000156459021010727 Filed on March 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SDGR
Schrodinger, Inc. Stock $sdgr